MUC5AC and cancer: We review the current literature on the analysis of mucins as biomarkers for the early detection of major epithelial cancers that contribute significantly to cancer-related deaths and are also known for predominant mucin deregulation, such as lung, colon, pancreas, prostate, liver, breast, and ovary cancers.